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This study aimed to assess the ability of the activPAL monitor (commonly used for measuring 22 
Sedentary Behaviour (SB), sitting or reclining with low energy expenditure while awake) to measure 23 
moderate to vigorous physical activity (MVPA), by assessing its agreement with the concurrent 24 
measurement by ActiGraph monitor (commonly used for measuring MVPA) to identify if a single 25 
monitor could be used to measure both MVPA and SB.  A convenience sample of 24 adults (79% 26 
female; aged 23-60) wore an ActiGraph GT3X+ and an activPAL3 concurrently for one day during 27 
free-living activities.  Time spent in MVPA was calculated as an outcome measure using published 28 
methods (ActiGraph, n=6; activPAL n=4).  Agreement was assessed between pairs of outcomes using 29 
the Bland & Altman method. Participants engaged in between 60 and 145 minutes of MVPA.  The 30 
activPAL method summing time walking with a cadence ≥100 steps/min underestimated MVPA 31 
compared with the ActiGraph but had the lowest aggregate bias (-16 minutes).  Other activPAL 32 
methods, based on acceleration counts and the embedded MET algorithm, overestimated MVPA 33 
compared to the ActiGraph. The study was limited by the lack of activPAL acceleration count 34 
methods developed for adults. With the recommended methods, the activPAL could be suitable for 35 
use as a single monitor to measure both SB and MVPA. 36 
 37 
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 aP3: method of calculating MVPA from the activPAL monitor using a value of 3METs from the 
embedded MET algorithm; aP100: method of calculating MVPA from the activPAL using 100 
steps/minute cadence; aP1418: method of calculating MVPA from the activPAL using an acceleration 
threshold of 1418; aP2997: method of calculating MVPA from the activPAL using an acceleration 
threshold of 2997; AG56: method of calculating MVPA from the ActiGraph monitor using a VM 
threshold of 56 counts per 1s epoch; AG1952: method of calculating MVPA from the ActiGraph 
monitor using a VT threshold of 1952 counts per minute (Freedson cut-points); AG2000 method of 
calculating MVPA from the ActiGraph monitor using a V T threshold of 2000 counts per minute (167 
counts per 5s epoch); AG2020: method of calculating MVPA from the ActiGraph monitor using a VT 
threshold of 2020 counts per minute; AG2960 method of calculating MVPA from the ActiGraph 
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       Lack of physical activity (PA) is a leading risk factor for mortality worldwide. A third (31%) of 42 
adults are physically inactive [1] causing approximately 3.2 million deaths every year [2,3] and 43 
representing a substantial global financial burden [4]. Engaging in a combination of moderate and 44 
vigorous PA (MVPA; ≥3 METs (metabolic equivalents) [5]) provides benefits for health, fitness and 45 
body composition [6]
 
and forms a key element in worldwide PA guidelines. More recently, sedentary 46 
behaviour (SB; defined as sitting or reclining while awake [7]) has been investigated as a behaviour 47 
distinct from lack of physical activity (physical inactivity). SB has a detrimental effect on health, 48 
mortality and cardiometabolic disease [8,9], which may be independent of PA. Measurement of both 49 
PA and SB is required to monitor population levels (surveillance), and to assess the effects of 50 
epidemiological and intervention studies [10]. Long-term (e.g. 1 week) objective measurement of both 51 
PA and SB during daily life is available through use of body-worn sensors.  However, a range of 52 
different monitors are available, differing by wear location and monitor output, with relative strengths 53 
and weaknesses [11-13].  This can make appropriate monitor selection for research difficult and may 54 
compromise direct comparison of outcome measures from studies using different monitors. 55 
       The most widely used accelerometer to measure PA for research is the ActiGraph (ActiGraph 56 
LLC, Pensacola, FL) accelerometer [14]. Usually worn at the hip, and sampled at 30-100Hz, the 57 
output is expressed as ‘counts’ (a proprietary value related to acceleration) aggregated over a user-58 
specified ‘epoch’ (time interval) [15]. Acceleration counts are translated into meaningful output (e.g. 59 
time spent in MVPA) using ‘cut-points’, which are threshold values derived from calibration and 60 
validation studies against the corresponding MET value for the PA being performed [15].  Whilst the 61 
ActiGraph is acknowledged as an appropriate monitor to measure time spent in MVPA, the selection 62 
of cut-point is dependent on epoch length [16], and there is disagreement as to which are most 63 
accurate [15].  For measurement of SB, the ActiGraph uses a low count cut-point to distinguish sitting 64 
from light PA.  Worn on the hip, the ActiGraph is unable to measure the posture of sitting, instead 65 
                                                                                                                                                                                    
monitor using a VM threshold of 2960 counts per minute; AG3208 method of calculating MVPA 
from the ActiGraph monitor using a VM threshold of 3208 counts per minute; LOA: limits of 
agreement; MET: metabolic equivalent; MVPA: moderate to vigorous physical activity; PA: physical 




measuring a lack of movement, which may misclassify some standing activities as SB, e.g. washing 66 
up [17]. 67 
      An alternative monitor option, growing in popularity, is the activPAL (PAL Technologies Ltd, 68 
Glasgow, UK).  This accelerometer-based monitor is worn on the anterior thigh and uses thigh 69 
inclination to distinguish between the postures of sitting and standing [18]. The activPAL has a 70 
sensitivity of 98% in adults for measuring SB against observation [19], and is regarded as the gold 71 
standard for measuring time spent in SB [20].  Whilst the activPAL also distinguishes between time 72 
spent standing and walking, with an accuracy of approximately 98% [21], time spent in MVPA is not 73 
one of its standard outputs.  Options for converting activPAL output into time spent in MVPA are 74 
varied and have only limited validation.  They include, use of the integral (embedded) activPAL 75 
output of METs generated from standard values for the posture or cadence of walking [22], use of 76 
cadence of walking to identify MVPA walking bouts [23] or use of the raw acceleration output to 77 
generate cut-points for MVPA [24]. 78 
        Given the complex interplay between SB, PA and health [25], the simultaneous measurement of 79 
both SB and PA has become important in public health research.  Many researchers opt to ask their 80 
participants to wear two monitors, one optimised to assess MVPA (e.g. the ActiGraph) and one 81 
optimised to measure SB (e.g. the activPAL).  However, having a single instrument that is valid and 82 
reliable to measure both SB and MVPA would be more convenient and cost efficient [16,26,27]. 83 
Previous studies comparing concurrent measures of both the ActiGraph and the activPAL to a 84 
criterion measure (direct/video observation or a wearable camera), have been conducted only for the 85 
assessment of time spent in SB [19,20,28].  In each case, the activPAL provided a more accurate 86 
measure of time spent in SB (compared to the criterion) than the ActiGraph.  For example, the 87 
Youden Index (combined effect of sensitivity and specificity) was 92% for the activPAL compared to 88 
75% for the ActiGraph [28].  The activPAL is recommended for measurement of SB [20,28], and is 89 
frequently used as the referent standard to measure SB in studies assessing concurrent validity of the 90 
ActiGraph [e.g. 16,30,31].  The concurrent agreement of the ActiGraph and the activPAL to measure 91 
MVPA has not been evaluated in free-living studies (with or without a criterion measure). 92 
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The inherent inability of an ActiGraph worn at the hip to distinguish between the postures of sitting 93 
and standing [17], means that it may not be suitable for use as a single monitor to assess MVPA and 94 
SB.  Therefore, the current study aimed to explore the ability of the activPAL to measure MVPA, by 95 
assessing the concurrent agreement of published methods to classify MVPA using the activPAL and 96 
the ActiGraph in a free-living environment. 97 
Methods 98 
         Study Design.  In this cross-sectional study, participants wore an ActiGraph and an activPAL 99 
monitor concurrently during one day of free-living activity, to assess the agreement in time spent in 100 
MVPA measured by the two monitors. 101 
        Participants.  A convenience sample was recruited via email invitations to staff and students 102 
from the School of Health and Life Sciences, Glasgow Caledonian University. Participants were 103 
adults, aged between 18 and 65, without any upper- or lower- limb functional impairment, 104 
neurological conditions affecting upper- or lower- limb function or a known allergy to the material 105 
used to attach the monitors. Ethical approval was provided by the School of Health at Glasgow 106 
Caledonian University ethics committee, and informed consent was obtained from all participants 107 
before data collection. 108 
         Protocol.  Participants were met on Day 0 by a researcher, and answered self-reported 109 
demographic questions (age, gender, height and weight).  Two monitors (activPAL3; ActiGraph 110 
GT3X) were attached to the participant, and a diary to record wear times for the monitors was 111 
provided.  Participants wore the monitors on Day1 (including overnight for the activPAL), and 112 
recorded sleep times and time for monitor attachment/removal in the diary.  Participants met the 113 
researcher on Day 2 to return the monitors. 114 
         Participants wore an activPAL3 (27g; 3.8×3.7×1.8cm), programmed for immediate start and set 115 
to record for 3 days.  The activPAL was worn on the midline on the anterior aspect of the thigh, at the 116 
midpoint between knee and hip joint, and was attached by the researcher using double sided 117 
hypoallergenic adhesive pads (PAL stickies, PAL technologies, Glasgow, UK).  Participants were 118 
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instructed to wear the monitor including overnight, but the monitor was not waterproofed and was 119 
removed for water-based activities. 120 
         Participants wore an ActiGraph GT3X (15g; 5.3×3.5×0.7cm), programmed to record data at 121 
80Hz.  ActiGraph monitors were worn on the axillary line of right iliac crest using an elastic strap 122 
provided by the manufacturer.  Participants attached the monitor themselves and monitors were not 123 
worn overnight or during water-based activities.  124 
         Data Processing.  Comparisons between the outputs of the two monitors were made within 125 
subjects using the data recorded on Day 1 in the period when both monitors were worn. The range of 126 
time was selected according to the attachment and removal times recorded in the diary.  127 
         All the methods used in this study to classify MVPA have been previously published (Table 1).  128 
Four methods for classifying MVPA using the activPAL monitor were included, using three different 129 
types of monitor output (activity count from the raw acceleration data; MET values generated from 130 
activPAL’s embedded formula; cadence of walking events).  The two activity count methods were not 131 
developed for an adult population, but since there were no other methods that used the activPAL’s 132 
activity count, they were included in the current study.  Therefore, ActiGraph methods developed for 133 
both adult and non-adult populations were also selected for inclusion.  As there is no agreement as to 134 
which ActiGraph cut-point is best, six published ActiGraph methods to derive MVPA were included 135 
in the current study. 136 
        ActivPAL data were downloaded using the activPAL professional software (version 6.4.1).  137 
MVPA was derived according to published methods, using the specified activPAL output.  For the 138 
two methods deriving MVPA from the activPAL raw acceleration (count) data [24,27], the 15s epoch 139 
output was used.  Both of these cut-points were developed using uniaxial activPAL monitors, 140 
therefore in this study only activity counts in the channel 1 (x-axis), the common channel shared by 141 
activPAL (uni-axial) and activPAL3 (tri-axial) monitors [32], were used to calculate MVPA.  Each 142 
15s epoch was categorised as MVPA if the activity count was above the specified cut-point (Table 1).  143 
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The sum of duration of 15s epochs categorised as MVPA was used to derive outcome measures of 144 
total time spent in MVPA. 145 
        The PAL embedded algorithm to calculate METs assigns METs values based on activity 146 
classification (sit/lie: 1.2METs; standing: 1.4MET; walking: varying linearly with cadence, walking at 147 
120 steps/minute is 4METs [33]). For the method deriving MVPA from the embedded MET 148 
algorithm [22], data were first reprocessed to change the embedded MET algorithm so that data 149 
categorised as standing was classified as 1.5METs.  Data was exported as an event file and was then 150 
extrapolated in to 1s epochs using an R package (activpalProcessing) [34].  The 1s epochs were 151 
categorised as MVPA if the METs calculated by the embedded activPAL algorithm were >2.99METs.  152 
The sum of duration of 1s epochs categorised as MVPA was used to derive outcome measures of total 153 
time spent in MVPA. 154 
         For the method using cadence, the event output was used to calculate MVPA.  Each event is 155 
defined as a continuous period of categorised activity [18]. Although a cadence of 100 steps/minutes 156 
has been advocated as a cut-point for moderate physical activity when walking (derived from 157 
validation studies [35-37]), the use of this cut-point as a measure of MVPA in activPAL derived 158 
walking had not been validated.  An excel macro (HSC PAL analysis software V2.21) was used to 159 
firstly create walking events from consecutive stepping events and calculate average cadence (number 160 
of steps in the event/event duration), and secondly to separate output into sedentary, standing and 161 
walking events. Walking events with an average cadence ≥100 steps/min were categorised as MVPA, 162 
and total time spent in MVPA was calculated as the sum of the duration of all such walking events. 163 
         ActiGraph data was downloaded using ActiLife software (version 5.10.0), and was exported in 164 
1s epochs. The six published ActiGraph cut-points selected for this study, varied in the epoch length 165 
over which counts were aggregated, the count cut-point used to define MVPA and the monitor axes 166 
used to provide the count value (vertical axis only (VT) or vector magnitude (VM)).  Specific values 167 
for these characteristics for each method can be found in Table 1.  The vector magnitude (VM) was 168 
calculated from three axes (square root of the sum of squares of each axis [38]).  Different epochs 169 
were subsequently created by summing up the 1s epochs on either vector magnitude (VM) or vertical 170 
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axis (VT). The sum of duration of appropriate epochs classed as MVPA (if greater than the cut-points 171 
for VT or VM, as appropriate) for each method was used to derive outcomes measures (one per 172 
method) of total time spent in MVPA. 173 
 174 
         Statistical analysis.  The outcome measures were total time spent in MVPA, calculated using 175 
four different activPAL methods and six different ActiGraph methods, reported as mean and standard 176 
deviation.  The Bland-Altman method was used to assess agreement between each pair of methods to 177 
derive MVPA.  Data are presented as mean and standard deviation of bias, and 95% Limits of 178 
Agreement (LOA; mean bias ±1.96 standard deviation), Bland-Altman diagrams for selected pairs are 179 
presented in the supplemental material.  To show the direction of bias, absolute difference was not 180 
used to calculate agreement. 181 
 182 
Results 183 
         Twenty-five adults participated in this study.  One set of activPAL data was missing due to 184 
technical issues (data did not download), therefore data from twenty-four individuals were included in 185 
this analysis.  Participants were mostly women (n=19; 79%), with an average age of 38±11 (23 to 60) 186 
years.  Four participants did not disclose their height and/or weight, and the remaining participants 187 
were on average overweight (mean BMI 27.92±2.79 kgm
-2
).  188 
        The mean time spent in MVPA ranged between 60 and 145 minutes (Table 2), with both the 189 
lowest and the highest times reported by activPAL methods. The six ActiGraph methods were more 190 
comparable, with mean time spent in MVPA ranging from 64 minutes to 94 minutes, whilst those that 191 
used the vertical axis only (VT) were spread across only 12 minutes (between 64 and 76 minutes).  192 
Grouping methods of defining MVPA by development population (refer to Table 1), the four methods 193 
developed for children and adolescents reported higher average time spent in MVPA (102±41 194 
minutes) than methods developed for adults (73±37 minutes). 195 
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        In general, the cadence-based activPAL method (aP100) tended to underestimate MVPA 196 
compared to the ActiGraph, whereas the other methods (based on METs and activity counts) tended 197 
to overestimate MVPA relative to ActiGraph methods (Table 2).  As expected, the activity count 198 
methods with the lower cut-points categorised more time as MVPA than those with higher cut-points.  199 
Amongst all activPAL methods, aP100 had the smallest average bias (-16±28 minutes) against all 200 
ActiGraph cut-points, compared with aP3 (17±27 minutes), aP2997 (18±28 minutes), and aP1418 201 
(69±44 minutes).  There were several specific pairs of methods with a small bias (Figure 1), the 202 
smallest bias was between aP3 and AG56 and between aP2997 and AG56.  However, as bias was 203 
calculated on signed (as opposed to absolute) data, this should be treated with caution due to the large 204 
95% LOA.  The smallest 95% LOA (range <90minutes) were between the cadence-based active PAL 205 
method (aP100) and the ActiGraph methods based on the vertical axis (AG1952, AG2000, AG2020).  206 
The aP1418 methods had the largest bias (50 to 80 minutes) coupled with large ranges between the 207 
95% LOA (160 to 180 minutes). 208 
        In general, methods using vector magnitude reported more time spent in MVPA than those using 209 
the vertical axis.  The ActiGraph methods based on the vertical axis agreed relatively closely with 210 
each other (bias <12 minutes, range of 95%LOA <40minutes, Table 3).  In particular, AG1952 and 211 
AG2020 (Figure 1e) were the most comparable methods with bias of -2 minutes and 95% LOA from -212 
6 to 2 minutes.  These two methods differed only in the activity count cut-point (~3%), whilst the 213 
epoch and axis used were the same. Two of the vector magnitude methods (AG56 and AG2690), had 214 
reasonable agreement with each other but not with the three vertical axis methods. However, the 215 
vector magnitude-based AG3208 appeared to agree better with the three VT methods than the other 216 
two VM methods. 217 
        In contrast to ActiGraph methods, the four ActivPAL methods showed little comparability with 218 
each other (Table 4).  For example, the pair of aP3 and aP100 had a bias of -33±19 minutes (95% 219 
LOA -72 to 5 minutes).  The pair of aP3 and aP2997 had a zero bias (Figure 1f), but the 95% LOA 220 





        The current study aimed to examine the agreement in measuring MVPA for adults in a free-224 
living environment between two objective monitors, the ActiGraph and the activPAL, using pre-225 
existing published methods to calculate MVPA.  The ActiGraph monitor is commonly used to 226 
measure MVPA in adults, and the study therefore aimed to assess whether the activPAL was also an 227 
acceptable tool to assess MVPA.  Across the ten methods tested, reported MVPA varied considerably, 228 
between 60 and 145 minutes (±40% of the mid-value).  As this was an agreement study without a 229 
criterion measure, the actual value of MVPA was not known.  In general, the activPAL cadence 230 
method (aP100) underestimated MVPA compared to ActiGraph methods, but had the smallest bias (-231 
16 minutes), and 95% LOA (<90 minutes).  Comparison with individual methods could be smaller, 232 
for example the bias of the aP100 method was -6 minutes compared with the popular ‘Freedson’ cut-233 
points (AG1952).  A bias of 16 minutes between methods can be considered large in terms of the 234 
amount of MVPA performed in a day, where achieving 22 minutes of MVPA each day would be 235 
sufficient to meet many PA guidelines.  However, this level of agreement was also similar to that 236 
between different pre-existing ActiGraph methods.  The use of activPAL to measure time spent in 237 
MVPA can therefore be placed within the same conversation as the relative merits of the different 238 
ActiGraph methods for measuring MVPA. 239 
       The embedded MET equation in the activPAL has been shown to both significantly under- and 240 
over-estimate actual energy expenditure in METs in adolescent and young adult females [26], and in 241 
young children [27].  However, while the value of the embedded activPAL MET algorithm might not 242 
provide an accurate estimate of energy expenditure, it can be used in adults to accurately categorise 243 
activity into SB and MVPA using the embedded METs estimates [22].  It should be noted, however, 244 
that the value that the embedded MET equation ascribed to standing was changed (from 1.4 to 1.5 245 
METs) from the default settings within the activPAL software.  It is possible that further refinement 246 
of the internal algorithm may improve MET classification.  Indeed, Harrington et al [26] found that 247 
the acceleration count output of the activPAL was better correlated to energy expenditure (r=0.76) 248 
than cadence (r=0.59).  However, in the current study, the cut-point for MVPA derived from counts 249 
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(in adolescent females, aP2997) did not perform better than the method based on the embedded MET 250 
algorithm (aP3). 251 
       The embedded MET algorithm method (aP3), when assessing MVPA, is based on the cadence of 252 
activity categorised as walking, with 3METs defined as being at a cadence of 74 steps/minute.  As the 253 
aP100 method consistently underestimated, and the aP3 consistently overestimated, time spent in 254 
MVPA compared to the ActiGraph it is possible that defining a value between 74 and 100 steps/min 255 
to represent MVPA would improve the calculation of time spent in MVPA.  In both methods, only 256 
periods of walking could be characterised as MVPA.  Any MVPA undertaken at other times, for 257 
example when standing or seated, would not be picked up.  However, it is unclear whether there 258 
would be sufficient hip acceleration for the ActiGraph to classify such periods as MVPA. In the 259 
current study, such activity is likely to have been missed by both monitors. 260 
         The predominant predictor of time spent in MVPA for each ActiGraph method appeared to be 261 
the axes used to generate counts (vertical axis or vector magnitude).  The exception was the AG3208 262 
VM-based method, which performed more like the VT methods than the other VM methods. One 263 
possible explanation for this is that this method was developed using artificial neural networks, as 264 
opposed to the more standard statistical methods of linear regression or optimising receiver operating 265 
characteristic curves used for all the other ActiGraph methods.  Except for development population, 266 
other aspects of the studies to derive cut-points were similar (e.g. oxygen consumption used as the 267 
criterion measure; walking and running always included in the protocol). 268 
         Many methods, for both activPAL and ActiGraph monitors, were developed on data from a uni-269 
axial monitor.  In the current study, only tri-axial monitors were used, and it was assumed during data 270 
processing that using the specified single axis value in the tri-axial monitor was equivalent to using a 271 
uni-axial monitor. However, any differences in the sensing units and data processing hardware 272 
between monitor models might affect the validity of that assumption. For activPAL, no studies have 273 
compared the value of the acceleration output between uni-axial and tri-axial models.  It is therefore 274 
unclear if any differences in value of the x-axis between the monitors exist, and thus whether the use 275 
of these activPAL cut-points developed using activity counts in a uniaxial activPAL are valid for a tri-276 
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axial activPAL.  However, the agreement in classification of activity (sit, stand, walk) between uni-277 
axial and tri-axial activPAL monitors, was good for standardised activities for children, adults [39] 278 
and older adults [40], but lower during simulated activities of daily living (ADL) for children and 279 
adults [39].  It is therefore possible that those differences in the value of x-axis acceleration might 280 
arise in a free-living environment, affecting the results of the current study. 281 
         All the VT cut-points of the ActiGraph were developed on uni-axial versions of the monitor.  In 282 
adults, there were no significant differences in vertical axis counts between a GT1M uniaxial 283 
ActiGraph and a GT3X tri-axial ActiGraph, when walking and running on a treadmill [41].  Bland 284 
and Altman analysis indicated a bias of 50 counts per minute between the monitors with 95% LOA of 285 
approximately ±700 counts per minute.  In children, using a 1 second epoch, agreement in vertical 286 
axis was good for static postures and walking, but was significantly higher in the GT3X for running 287 
and Wii boxing tasks [42].  For walking and running-based MVPA in adults, then, it seems reasonable 288 
to use the ActiGraph axes interchangeably. 289 
         Many studies have been conducted to examine the agreement between ActiGraph and activPAL 290 
in classifying SB [16,30,31], using activPAL as the reference standard, with the aim of identifying 291 
find the most comparable ActiGraph cut-points to measure SB. It is, however, clear that the 292 
ActiGraph does not adequately assess postural sitting, due to the nature of measuring acceleration at 293 
the hip [17,20,28].  Other than a lack of previous research interest, there is no equivalent reason to 294 
assume that the activPAL cannot adequately measure MVPA.  Therefore, a key strength of the current 295 
study was that it investigated a potentially realistic option for using a single monitor to adequately 296 
assess both MVPA and SB. 297 
         The study also had several weaknesses.  The study had a small sample size drawn only from a 298 
higher education setting, and therefore may not be generalisable to a wider population.  However, the 299 
use of concurrent measurement meant that comparison was made between monitors on the actual 300 
activity of the participant, regardless of how typical.  Another weakness was the lack of a criterion 301 
measure, so there was no knowledge of the actual MVPA of participants in the study.  This means that 302 
all assessment of agreement between methods was relative and not absolute.  However, there are 303 
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limited options to provide an adequate criterion method for free-living activity over a longer period 304 
(e.g. a day); indirect calorimetry cannot be comfortably worn for extended periods, and direct 305 
observation is potentially intrusive and time consuming to achieve.  In a study aiming to assess the 306 
potential of one monitor method to agree with another established monitor, concurrent measurement 307 
is an acceptable methodology. 308 
         A particular weakness of the current study was the inclusion, in a study with adult participants, 309 
of methods to derive MVPA developed for younger populations (adolescents and children).  This 310 
decision was driven by the lack of cut-points using activity count developed for the activPAL for 311 
adults, coupled with the desire to assess the potential utility of such methods for the calculation of 312 
MVPA.  It is unclear how different an adolescent population might be from the relatively young 313 
adults who participated in the current study, although the development of the adolescent cut-point 314 
including only female participants is an additional limitation.  However, in the current study, this 315 
method (aP2997) performed relatively similarly to one of the other activPAL methods derived for 316 
adults (aP3).  It is clear that the methods designed for children resulted in higher values of time spent 317 
in MVPA.  In particular, the method derived for the activPAL for 4-6 year olds resulted in a value of 318 
MVPA 50 minutes greater than any other outcome (145 minutes vs 94 minutes).  Further research is 319 
required to elucidate how different an activPAL cut-points using activity count developed for adults 320 
would be, and how well it would agree with ActiGraph assessments of MVPA. 321 
 322 
Conclusion 323 
The agreement of different methods of calculating MVPA (four using the activPAL monitor and six 324 
using the ActiGraph monitor) were assessed on concurrently measured free-living data in adults.  325 
Using a cadence of 100 steps/minute underestimated MVPA compared to ActiGraph methods, and 326 
had the lowest aggregate bias (-16 minutes).  Pairs of methods could have smaller bias, for example, 327 
the cadence method (aP100) and the ‘Freedson’ cut-points (AG1952) had a bias of -6 minutes.  Other 328 
activPAL methods, based on acceleration counts and the embedded MET algorithm, overestimated 329 
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MVPA compared to the Actigraph.  However, the study was limited by the lack of activPAL 330 
acceleration count methods developed specifically for an adult population.  The current study found 331 
that the comparisons between measuring MVPA using the activPAL were in the same range as 332 
comparisons between different ActiGraph cut-points.  As previous research has established that the 333 
activPAL is preferable to the ActiGraph for the measurement of SB, these results showing its 334 
comparability with ActiGraph for measuring MVPA, suggest that the activPAL may be suitable to use 335 
as a single monitor to adequately measure both SB and MVPA. 336 




 Different activity monitors measure moderate to vigorous physical activity (MVPA) in 339 
different ways, meaning comparison between studies can be difficult. 340 
 ActiGraph and activPAL can achieve good agreement in measuring MVPA by using 341 
particular pairs of methods. 342 
 Differences in MVPA measured between activPAL and ActiGraph monitors were comparable 343 
to differences between different ActiGraph methods. 344 
 Using the threshold of 100 steps/min to measure MVPA in activPAL had best agreement with 345 
ActiGraph, and is therefore recommended to be used to measure MVPA.  346 
 ActivPAL can be used as a single monitor to measure both physical activity and sedentary 347 
behaviour since it is good for measuring sedentary behaviour, and this study showed it can 348 
measure MVPA in good agreement with ActiGraph. . 349 
  350 
16 
 
Figure Captions 351 
Bland -Altman plots of mean bias in time spent in MVPA and 95% limits of agreement for time spent 352 
in MVPA measured by (a) aP3-AG56 (b) aP2997 - AG56 (c) aP100-AG2020 (d) aP100-AG1952 (e) 353 
AG1952-AG2020 (f) aP3-aP2997. 354 
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Table 1: Characteristics of previously published methods to categorise time spent in MVPA (as used in the current study). 
Reference Monitor Acronym output axes Cut-point value Epoch Development Population 
[22] 
activPAL 
aP3 MET -- 2.99 1s Adults 
[35-37] aP100 cadence -- 100 per event Adults 
[27] aP1418 activity counts thigh 1418 15s Children 
[24] aP2997 activity counts thigh 2997 15s Adolescents 
[43] 
ActiGraph 
AG1952 activity counts VT 1952 60s Adults 
[44] AG2000 activity counts VT 166.7
1
 5s Children 
[45] AG2020 activity counts VT 2020 60s Adults 
[42] AG56 activity counts VM 56 1s Children 
[41] AG2690 activity counts VM 2690 60s Adults 
[46] AG3208 activity counts VM 3208 60s Adults 
MET: Metabolic equivalent; MVPA: moderate to vigorous physical activity; VT vertical axis; VM: vector magnitude. Time spent in MVPA reported as mean 
± standard deviation. 
1




Table 2:  Mean time spent in MVPA, bias and 95% limits of agreement for MVPA between pairs of activPAL and ActiGraph methods 
  activPAL 
 method METs Cadence Activity Counts 
 acronym aP3 aP100 aP1418 aP2997 
 [Mean ± SD] [93 ± 41] [60 ± 32] [145 ± 58] [93 ± 43] 
ActiGraph      
axes acronym [Mean ± SD] Bias  (95% LOA) Bias  (95% LOA) Bias  (95% LOA) Bias  (95% LOA) 
VT 
AG1952 [66± 36] 27 ± 23  (-18 to 72)   -6 ± 22  (-50 to 37)  79 ± 43  (  -4 to 163) 27 ± 25  (-22 to 77) 
AG2000 [76± 31]  17 ± 24  (-30 to 64) -16 ± 23  (-61 to 28)  69 ± 42  (-14 to 152) 17 ± 26  (-34 to 68) 
AG2020 [64 ± 35]  29 ± 23  (-16 to 74)   -4 ± 21  (-46 to 38)  81 ± 43  (  -3 to 166)  29 ± 26  (-21 to 80) 
VM 
AG56 [94 ± 30]  -1 ± 30  (-61 to 58) -35 ± 32  (-97 to 28)  51 ± 44  (-35 to 137)    -1 ± 29  (-58 to 56) 
AG2690 [87 ± 41]    6 ± 32  (-56 to 69) -27 ± 36  (-98 to 43)  58 ± 45  (-31 to 147)    7 ± 31  (-55 to 68) 
AG3208 [67 ± 36]  26 ± 30  (-32 to 84)   -8 ± 31  (-68 to 52)  78 ± 46  (-13 to 168)  26 ± 28  (-30 to 82) 
LOA: limits of agreement; METs: metabolic equivalent; MVPA: moderate-vigorous physical activity; SD: standard deviation; VT: vertical axis; VM: vector 
magnitude.  Data presented as bias (activPAL method – ActiGraph method) mean ± standard deviation, and 95% LOA. 
27 
 
Table 3:  Bias and 95% limits of agreement for MVPA calculated between pairs of ActiGraph 
methods 
Axis  VT VM 
 acronym AG1952 AG2000 AG2020 AG56 AG2690 
VT 
AG2000 
 10 ± 10 
(-9 to 30) 
    
AG2020 
-2 ± 2 
(-6 to 2) 
-12 ± 10 
(-32 to 7) 
   
VM 
AG56 
28 ± 21 
(-12 to 69) 
18 ± 16 
(-13 to 50) 
30 ± 20 
(-10 to 70) 
  
AG2690 
21 ± 19 
(-16 to 57) 
11 ± 19 
(-27 to 49) 
23 ± 20 
(-15 to 61) 
-8 ± 16 
(-38 to 23) 
 
AG3208 
1 ± 14 
(-27 to 29) 
-9 ± 16 
(-40 to 22) 
3 ± 15 
(-25 to 32) 
-27 ± 14 
(-54 to 0) 
-20 ± 10 
(-40 to 1) 
VT: vertical axis; VM: vector magnitude.  Data presented as bias (row - column) mean ± standard 




Table 4:  Bias and 95% limits of agreement for MVPA calculated between pairs of activPAL 
methods 
Output  METs cadence activity counts 
 acronym aP3 aP100 aP1418 
cadence aP100 
-33 ± 19 




52 ± 27 
(-1 to 105) 
85 ± 42 
(3 to 168) 
 
aP2997 
0 ± 15 
(-28 to 29) 
34 ± 25 
(-16 to 83) 
-52 ± 24 
(-98 to -6) 
METs: metabolic equivalents. Data presented as bias (row - column) mean ± standard deviation (95% 





















Figure 1 Bland -Altman plots of mean bias in time spent in MVPA and 95% limits of agreement for 
time spent in MVPA measured by (a) aP3-AG56 (b) aP2997-AG56 (c) aP100-AG2020 (d) aP100-
AG1952 (e) AG1952-AG2020 (f) aP3-aP2997. 
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